NCT06184893View on ClinicalTrials.gov

Rheumatoid Arthritis-associated Interstitial Lung Disease Definition

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Rheumatoid Arthritis-Associated Interstitial Lung Disease

Trial Locations (1)

4000

RECRUITING

Centre Hospitalier Universitaire de Liege, Liège

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Centre Hospitalier Universitaire de Liege

OTHER

NCT06184893 - Rheumatoid Arthritis-associated Interstitial Lung Disease Definition | Biotech Hunter | Biotech Hunter